Aurobindo Pharma Limited — Clarithromycin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Clarithromycin · $1.8M export value · DGFT Verified
Aurobindo Pharma Limited is the #9 Indian exporter of Clarithromycin with $1.8M in export value and 35 verified shipments. Aurobindo Pharma Limited holds a 1.8% market share in Clarithromycin exports across 3 countries. The company exports 81 pharmaceutical products worth $1.1B across 18 therapeutic categories.
Aurobindo Pharma Limited — Clarithromycin Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Limited Export Clarithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.3M | 60 | 48.3% |
| UNITED KINGDOM | $1.1M | 43 | 22.5% |
| MALTA | $701.0K | 64 | 14.6% |
| TANZANIA | $270.5K | 19 | 5.6% |
| UNITED STATES OF AMERICA | $150.0K | 3 | 3.1% |
| SOUTH AFRICA | $133.6K | 13 | 2.8% |
| SINGAPORE | $78.9K | 5 | 1.6% |
| HONG KONG | $33.8K | 5 | 0.7% |
| PORTUGAL | $21.6K | 1 | 0.4% |
| FRANCE | $18.4K | 1 | 0.4% |
Aurobindo Pharma Limited exports Clarithromycin to 11 countries. The largest destination is UNITED STATES accounting for 48.3% of Aurobindo Pharma Limited's Clarithromycin shipments, followed by UNITED KINGDOM (22.5%) and MALTA (14.6%). These destinations reflect Aurobindo Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Clarithromycin from Aurobindo Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MILPHARM LIMITED | UNITED KINGDOM | $746.5K | 33 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $598.6K | 15 |
| RISING PHARMA HOLDINGS, INC. | UNITED STATES | $483.2K | 13 |
| APL SWIFT SERVICES MALTA LTD | MALTA | $401.6K | 29 |
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $385.5K | 11 |
| RISING PHARMA HOLDINGS INC | UNITED STATES OF AMERICA | $300.0K | 6 |
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $271.7K | 21 |
| AUROLOGISTICS LLC | UNITED STATES | $224.5K | 6 |
| GENERICS & SPECIALITIES LTD, | TANZANIA | $182.6K | 13 |
| AUROBINDO PHARMA USA INC., | UNITED STATES | $150.0K | 3 |
Aurobindo Pharma Limited supplies Clarithromycin to 36 buyers globally. The largest buyer is MILPHARM LIMITED (UNITED KINGDOM), followed by AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES) and RISING PHARMA HOLDINGS, INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Clarithromycin Export Value and How Much Does Aurobindo Pharma Limited Contribute?
India exported $61.2M worth of Clarithromycin through 3,576 shipments from 334 suppliers to 144 countries, serving 811 buyers globally. Aurobindo Pharma Limited contributes $1.8M to this total, accounting for 1.8% of India's Clarithromycin exports. Aurobindo Pharma Limited ships Clarithromycin to 11 countries through 36 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Limited's Clarithromycin Exports?
Aurobindo Pharma Limited's average Clarithromycin shipment value is $50.0K per consignment, based on 35 shipments totaling $1.8M. The largest destination is UNITED STATES (48.3% of Aurobindo Pharma Limited's Clarithromycin exports).
How Does Aurobindo Pharma Limited Compare to Other Indian Clarithromycin Exporters?
Aurobindo Pharma Limited ranks #9 among 334 Indian Clarithromycin exporters with a 1.8% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($15.4M), MICRO LABS LIMITED ($15.4M), AUROBINDO PHARMA LTD ($7.8M). Aurobindo Pharma Limited processed 35 shipments to 3 destination countries.
What Clarithromycin Formulations Does Aurobindo Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CLARITHROMYCIN TABLETS 500 MG (CLARITHROMYCIN 500 MG FILM-COATED TABLETS) 2X7'S | $357.6K | 11 |
| CLARITHROMYCIN TABLETS 500 MG (11760X60' | $300.0K | 6 |
| CLARITHROMYCIN TABLETS 500 MG(Clarithrom | $235.5K | 6 |
| CLARITHROMYCIN TABLETS 500 MG (Claritrom | $202.7K | 12 |
| CLARITHROMYCIN TABLETS 500 MG (CLARITHRO | $150.0K | 3 |
| CLARITHROMYCIN TABLETS 500 MG (CLARITHROMYCIN TABLETS USP 500 MG) 60'SNOS | $150.0K | 3 |
| CLARITHROMYCIN TABLETS 500 MG (28560X60S)NOS | $150.0K | 3 |
| CLARITHROMYCIN TABLETS 500 MG (27168X60S) | $150.0K | 3 |
| CLARITHROMYCIN TABLETS 500 MG(CLARITHROMYCIN TABLETS USP 500 MG) 60'S | $150.0K | 3 |
| CLARITHROMYCIN TABLETS 500 MG (KLAR 500) | $131.8K | 8 |
Aurobindo Pharma Limited exports 119 distinct Clarithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CLARITHROMYCIN TABLETS 500 MG (CLARITHROMYCIN 500 MG FILM-CO with 11 shipments worth $357.6K.
Regulatory Requirements: Exporting Clarithromycin to Key Markets
What Aurobindo Pharma Limited must comply with to export Clarithromycin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Limited Compare to Nearest Clarithromycin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | CIPLA LIMITED | $2.1M | 43 | 6 | $50.0K |
| 6 | WEXFORD LABORATORIES PRIVATE LIMITED | $1.8M | 35 | 4 | $50.0K |
| 9 | AUROBINDO PHARMA LIMITED ★ | $1.8M | 35 | 3 | $50.0K |
| 12 | MEDICO REMEDIES LIMITED | $1.3M | 42 | 6 | $30.5K |
| 11 | MEDLEY PHARMACEUTICALS LIMITED | $1.1M | 22 | 2 | $50.0K |
Aurobindo Pharma Limited ranks #9 among 334 Indian Clarithromycin exporters. Average shipment value of $50.0K compared to the market average of $183.3K. The closest competitors by value are CIPLA LIMITED and WEXFORD LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Clarithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 365 | 10.2% |
| DELHI AIR CARGO ACC (INDEL4) | 296 | 8.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 282 | 7.9% |
| DELHI AIR | 258 | 7.2% |
| NHAVA SHEVA SEA (INNSA1) | 229 | 6.4% |
| JNPT/ NHAVA SHEVA SEA | 156 | 4.4% |
| JNPT | 125 | 3.5% |
| DHANNAD ICD | 124 | 3.5% |
About Aurobindo Pharma Limited
Aurobindo Pharma Limited exports 81 products worth $1.1B. Beyond Clarithromycin, top products include Amoxicillin, Potassium, Pantoprazole, Clopidogrel, Rosuvastatin. View the complete Aurobindo Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Clarithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Clarithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 218 individual customs records matching Aurobindo Pharma Limited exporting Clarithromycin, covering 119 formulations to 11 countries via 36 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 144+ countries, 811+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Clarithromycin Export Data from Aurobindo Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Limited's Clarithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Limited
Full Company Profile →
81 products · $1.1B total trade · 18 categories
Clarithromycin Stats
Company Overview
Top Products by Aurobindo Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Clarithromycin. For current shipment-level data, contact TransData Nexus.